Windtree Therapeutics Future Growth
Future criteria checks 0/6
Windtree Therapeutics's earnings are forecast to decline at 84.7% per annum. EPS is expected to grow by 136.7% per annum.
Key information
-84.7%
Earnings growth rate
136.7%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 09 Jul 2024 |
Recent future growth updates
Recent updates
Windtree Therapeutics CEO Craig Fraser - Breaking Down Acute Heart Failure (Video)
Dec 06Windtree Therapeutics: Addressing Underserved And Expensive Acute Conditions
Jul 06Shareholders Will Likely Find Windtree Therapeutics, Inc.'s (NASDAQ:WINT) CEO Compensation Acceptable
Jun 09
Should You Take Comfort From Insider Transactions At Windtree Therapeutics, Inc. (NASDAQ:WINT)?
Feb 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | N/A | -27 | N/A | N/A | 1 |
| 12/31/2024 | N/A | -5 | N/A | N/A | 1 |
| 6/30/2024 | N/A | -11 | -13 | -13 | N/A |
| 3/31/2024 | N/A | -6 | -14 | -14 | N/A |
| 12/31/2023 | N/A | -20 | -13 | -13 | N/A |
| 9/30/2023 | N/A | -25 | -13 | -13 | N/A |
| 6/30/2023 | N/A | -24 | -13 | -13 | N/A |
| 3/31/2023 | N/A | -35 | -15 | -15 | N/A |
| 12/31/2022 | N/A | -39 | -19 | -19 | N/A |
| 9/30/2022 | N/A | -43 | -21 | -21 | N/A |
| 6/30/2022 | N/A | -47 | -22 | -22 | N/A |
| 3/31/2022 | N/A | -67 | -25 | -24 | N/A |
| 12/31/2021 | N/A | -68 | -24 | -24 | N/A |
| 9/30/2021 | N/A | -62 | -24 | -23 | N/A |
| 6/30/2021 | N/A | -63 | -27 | -26 | N/A |
| 3/31/2021 | N/A | -35 | -26 | -26 | N/A |
| 12/31/2020 | N/A | -33 | -26 | -25 | N/A |
| 9/30/2020 | N/A | -32 | -26 | -26 | N/A |
| 6/30/2020 | N/A | -31 | -22 | -22 | N/A |
| 3/31/2020 | 0 | -27 | -22 | -21 | N/A |
| 12/31/2019 | 0 | -27 | -25 | -25 | N/A |
| 9/30/2019 | 1 | -43 | -26 | -25 | N/A |
| 6/30/2019 | 1 | -40 | -25 | -25 | N/A |
| 3/31/2019 | 2 | -37 | -22 | -22 | N/A |
| 12/31/2018 | 2 | -35 | -16 | -16 | N/A |
| 9/30/2018 | 2 | -9 | -14 | -14 | N/A |
| 6/30/2018 | 1 | -13 | -14 | -14 | N/A |
| 3/31/2018 | 1 | -17 | N/A | -16 | N/A |
| 12/31/2017 | 1 | -25 | N/A | -21 | N/A |
| 9/30/2017 | 2 | -34 | N/A | -23 | N/A |
| 6/30/2017 | 3 | -35 | N/A | -28 | N/A |
| 3/31/2017 | 2 | -38 | N/A | -32 | N/A |
| 12/31/2016 | 2 | -39 | N/A | -34 | N/A |
| 9/30/2016 | 2 | -43 | N/A | -34 | N/A |
| 6/30/2016 | 1 | -56 | N/A | -33 | N/A |
| 3/31/2016 | 1 | -57 | N/A | -34 | N/A |
| 12/31/2015 | 1 | -55 | N/A | -34 | N/A |
| 9/30/2015 | 2 | -56 | N/A | -36 | N/A |
| 6/30/2015 | 2 | -45 | N/A | -39 | N/A |
| 3/31/2015 | 3 | -45 | N/A | -40 | N/A |
| 12/31/2014 | 3 | -44 | N/A | -41 | N/A |
| 9/30/2014 | 2 | -45 | N/A | -41 | N/A |
| 6/30/2014 | 1 | -46 | N/A | -40 | N/A |
| 3/31/2014 | 0 | -44 | N/A | -40 | N/A |
| 12/31/2013 | 0 | -45 | N/A | -40 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WINT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: WINT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: WINT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if WINT's revenue is forecast to grow faster than the US market.
High Growth Revenue: WINT is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if WINT's Return on Equity is forecast to be high in 3 years time